Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000680590 | SCV000808015 | likely benign | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000690352 | SCV000818034 | likely benign | Adams-Oliver syndrome 5 | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000690352 | SCV002554457 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270961 | SCV002554458 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003432725 | SCV004162029 | uncertain significance | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | NOTCH1: PP2, BP4 |
Ambry Genetics | RCV004026160 | SCV005027211 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-01-29 | criteria provided, single submitter | clinical testing | The p.R1287H variant (also known as c.3860G>A), located in coding exon 23 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 3860. The arginine at codon 1287 is replaced by histidine, an amino acid with highly similar properties. This alteration has been reported in a congenital heart disease cohort (Preuss C et al. PLoS Genet, 2016 Oct;12:e1006335). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |